Ionis Pharmaceuticals in (ions 0 04/01/26)
13F holders, Q3 2025 (September 30)7holders +1
2new positions
1sold out
$1.22avg. 13F price*
At the end of Q3 2025, 7 institutions reported holding Ionis Pharmaceuticals in (ions 0 04/01/26) in their 13F filings, up 1 from Q2 2025. 2 opened new positions and 1 sold out. The largest holders were BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($612K), Bank of New York Mellon Corp ($359K) and Sonora Investment Management Group, LLC ($196K).
- Company
- Ionis Pharmaceuticals in (ions 0 04/01/26)
- CUSIP
- 462222AD2
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $27K |
| Exits | 1 | $56K |
All 13F filers, Q2 2025 → Q3 2025: 125,000 shares bought and 54,910 shares sold, net +70,090 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.00% | No change | 500,000 | $612K |
| Bank of New York Mellon Corp | 0.00% | Add +50.0% | 300,000 | $359K |
| Sonora Investment Management Group, LLC | 0.01% | No change | 160,000 | $196K |
| Oppenheimer Asset Management Inc. | 0.00% | Add +3.3% | 95,000 | $117K |
| Stephens Inc. | 0.00% | No change | 26,000 | $32K |
| Traub Capital Management LLC | 0.02% | New | 17,000 | $21K |
| Fifth Third Bancorp | 0.00% | New | 5,000 | $6K |
"% of holder's portfolio" is IONIS PHARMACEUTICALS IN (IONS 0 04/01/26)'s weight in each manager's 13F, not the share of Ionis Pharmaceuticals in (ions 0 04/01/26) the manager owns.